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In adult rats, antagonisni of the 5-HT3 serotonin receptor blocks
 
the acquisition Of a morphine-induced conditioned place preference
 
(CPP). In the present study, the ability of the selective 5-HT3 serotonin
 
receptor antagonist MDL-72222 to modulate the acquisition and
 
expression of cocaine- and morphine-induced CPP was assessed in 17-day­
old rats. An abbreviated CPP procedure was used in which rats received
 
two saline-odor (lemon or almond^ pairings on the first conditioning
 
day, and two saliner, cocaine-, or morphine-odor pairings on the second
 
day. Preference was assessed on the third day. To determine the effects of
 
5-HT3 receptor antagonism on the acquisition of CPP, rats were given
 
MDL-72222 (0.5-4.5 mg/kg), IP) 30 min prior to being conditioned with
 
cocaine (20.0 mg/kg, IP) or morphine (0.5 mg/kg, IP). To determine the
 
effects of 5-HT3 receptor antagonism on the expression of CPP, rats were
 
injected with MDL-72222 30 min prior to preference testing. As expected,
 
both cocaine and morphine produced robust place preference
 
cohditioning in preweanling rats. Surprisingly, MDL-72222 did not affect
 
the acquisition or expression of cocaine- or morphine-induced CPP. These
 
results suggest that the 5-HT3 serotonin receptor system may
 
differentially modulate DA- and opioid-mediated reward across
 
ontogeny. The known peak surge in the density of certain dopamine
 
-.iii; ■ . 
receptor subtypes within the mesolimbic system coincide with the
 
preweanling stage of development. An animal's ability to acquire and
 
express memories and behaviors related to rewarding experiences
 
depends upon the robust functioning of the reward center. The mastery
 
required to survive the weaning period may depend upon a temporary
 
alteration in neurotransmisson that reduces the risk of lowering reward
 
functioning.
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OVERVIEW
 
Science is revealing that a homeostasis exists within an
 
individual's normal brain chemistry. Disruption of the functional
 
stability between the levels of various neurochemicals can lead to
 
temporary or permanent disease. No area of the brain is more important
 
to an individual's psychological health than the mesolimbic system
 
(Davis, Kahn, Ko, & Davidson, 1991). This system has been implicated in
 
the sense of mental well being and in the reinforcement properties of
 
drugs of addiction (Nathan, Dominique, Schatzberg, & Nemeroff, 1995;
 
Wise & Bozarth, 1987).
 
Evidence from several experimental paradigms have implicated
 
the dopamine (DA) pathway in an endogenous system of reward
 
(Ettenberg & Camp, 1986; Olds, 1978). Instrumental conditioning,
 
operant conditioning and conditioned place preference (CPP) studies
 
have suggested that DA neurotransmission is essential for the
 
establishment of the natural reinforcement properties of satiation, as
 
well as the addictive qualities of substances of abuse (Beninger et al.,
 
1987; Fibiger & Phillips, 1982; Wise & Bozarth, 1987; Wise, Spindler, &
 
Legault, 1978). Additionally, both the acquisition and expression of
 
conditioned behaviors are shown to be mediated by separate DA receptor
 
mechanisms (Hiroi & White, 1989, 1990; Spyraki, Fibiger, & Phillips,
 
1982a; White & Garr, 1984, 1985).
 
Through manipulations of the specific neurochemicals that are
 
involved in reinforcement, the reward pathway has been shown to be
 
stimulated by drugs that activate DA neurons, causing DA release into
 
the nucleus accumbens (NA) (deWit & Wise, 1978; DiChiara & Imperato,
 
1988; DiChiara & North, 1992; Grant, 1995; Gysling & Wang, 1983;
 
Shippenberg, Bals-Kubik, & Herz, 1993; Wise & Bozarth, 1987). Addictive
 
drugs that excite the DA reward system, such as morphine and cocaine^
 
allow the acquisition and expression of reward; whereas, neurochemicals
 
that antagonize DA neurotransmission appear capable of suppressing
 
reward (Calcagnetti, Keck, Quartrella, & Schechter, 1995; DiChiara &
 
North, 1992; Hoffman, 1989; Wise & Bozarth, 1987). The expression of
 
reinforced behavior is believed related to the mnemonic aspects of
 
reward, possibly through afferents coming into the NA from the
 
amygdala (Hiroi & White, 1991).
 
Thus, DA maintains a central place of importance in the reward
 
process (DiChiara & Imperato, 1988) In addition to the role played by
 
mesolimbic DA neurons and their fiber pathways, evidence has
 
implicated the existence of other neurotransmitters within the reward
 
system (Costall, Naylor, Mardens, & Pycock, 1976; DiChiara & North,
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1992). For example, both the serotonin and opioid systems modulate the
 
DA reward pathway. These two neurotransmitter systems have been
 
implicated in the normal functioning of reward mechanisms and may
 
impact the effects that addictive drugs have on behavior (Costall et al.,
 
1976; DiChiara & North, 1992; Imperato & Angelluci, 1989; Spahagel,
 
Herz, & Shippenberg, 1992). Consequently, experimental research has
 
begun to focus on the role played by serotonin in the reward process
 
(Grant, 1995; Imperato & Angelucci, 1989). Studies of serotonin agonists
 
and antagonists have provided evidence that the serotonin receptor is
 
important for reward. Antagonism of the serotonin receptor subtyjpe 5­
HTs appears to abolish drug-induced reward (Joharchi, Sellars, & Higgins,
 
1993; Suzuki, Shiozaki, Masukawa, & Misawa, 1992). This suggests that
 
serotonin regulates mesolimbic DA neufotransmissiOn (Carboni, Acquas,
 
Frau, & DiChiara, 1989; Imperato & Angelucci, 1989).
 
There are indications that a functioning reward system exists in
 
preweariling rats, although some interesting age-dependent differences
 
have been reported (McDougall, Nonneman, & Crawford, 1991). Evidence
 
indicates that in addition to a fairly mature endogenous reward system,
 
neonates also have the ability to respond to drugs with reinforcing
 
properties. Morphine and cocaine enhance DA levels in preweanling rats,
 
an effect that also enhances reinforced behaviors. Consequently,
 
blockade of DA receptors attenuates the reinforcing properties of drugs
 
like morphine and cocaine (Barr & Rossi, 1992; Laviola, beU'Omo, Alleve,
 
& Bignami, 1992; Pruitt, Bolanos, & McDougall, 1995).
 
It also appears that preweanling rats have a fully developed
 
serotonin system, as receptor binding studies demonstrate' that serotonin
 
receptors are in place and functioning shortly after birth (Daval et al.,
 
1987; Laviola et al., 1992; Pranzatelli, 1992). However, little is known
 
about the interaction between the DA and serotonin systems in the
 
preweanling rat, so it is uncertain whether the sefotonin system
 
modulates reward functioning in these young animals. Additionally, it
 
has never been determined what brain areas are responsible for
 
serotonin's reward attenuation abilities or whether separate mechanisms
 
control the acquisition and expression of reward. Therefore, the purpose
 
of this project is: first, to determine whether serotonin 5-HT3 receptor
 
antagonists will block both the acquisition and expression of DA and
 
opiate reward and, second, to determine what brain areas are critical for
 
serotonin's reward suppressing effects
 
INTRODUCTION
 
DA is enormously important to psychological welTbeing (Kapur «&
 
Remington, 1996). Pathology in DA pathways have been implicated in
 
mood disorders (Nathan et al., l995), the disordered thought and affect
 
in schizophrenia (Davis et al, 1991), the involuntary tier and co
 
of Tourette's disorder (Malison et al;, 1995), the motor impairments of
 
Parkinson's disease (Agid, 1991; Balk et al., 1995), the inattention and
 
hyperactivity in children with attentibn-deficit hyperactivity disorder
 
(ADHD) (Castellanos et al., 1994) and in the paranoid symptoms of
 
Alzheimer's disease (Nazarali & Reynolds, 1992). DA levels within the
 
mesolimbic DA reward pathway have also been directly implicated in
 
the rewarding properties of drugs of abuse (Wise & Bozarth, 1987). The
 
many devastating abnormalities in behavior that result from a
 
disruption of DA neurotransmission indicates its immense importance to
 
normal functioning.
 
Although the exact causes of schizophrenia, Alzheimer's Disease,
 
Tourette's Disorder and ADHD remain unknown, many of the symptoms
 
are alleviated by antagonism or agonism of DA system functioning. DA
 
receptor antagonists, such as chlorproinazihe and haloperidol, are used
 
to alleviate the psychotic symptoms of schizophrehia and Alzheimer's
 
disease (Davis et al., 1991; Nazarali & Reyhblds, 1992). Syinptoms of
 
Tourette's syndrome are also alleviated by DA antagonists (Malison et
 
al., 1995). Methylphenidate, an indirect DA agonist related to
 
amphetamine, is used successfully to treat many cases of ADHD
 
(Castellanos et al., 1994).
 
Many addictive drugs activate the DA system. Research utilizing
 
animal models of reward have implicated DA neurotransmission in the
 
rewarding effects of drug addiction (Bozarth & Wise, 1981; Hoffman,
 
1989; Wise, 1983). For example, systemic or localized injections of
 
addictive drugs, such as morphine, cocaine and amphetamine, increase
 
DA levels within the mesolimbic region of the rat brain (DiChiara &
 
Imperato, 1988; Wise & Bozarth, 1987). Conversely, antagonism of DA
 
receptors inhibits DA release and attenuates drug-induced behaviors in
 
rats (DiChiara & Imperato, 1988; Rompre & Wise, 1988; Yokel & Wise,
 
1976).
 
Thus, DA neurotransmission appears to have an important role in
 
normal functioning. Diseases of the nervous system or drug-induced
 
imbalances can cause disruptions in the DA pathways resulting in
 
pathological behaviors.
 
BASICSTRUCTUREANDFUNCTION OFDAPATHWAYS
 
The DA system has a highly organized arrangement of projections
 
that are classified into the nigrostriatal and mesolimbic-mesocortical
 
systems. The nigrostriatal system primarily extends from the substantia
 
nigra to the striatum (i.e., caudate-putamen). Additional DA fibers
 
project from the ventral tegmental area (VTA) to either the limbic
 
system (to form mesolimbic connections) or to the cortex (to form
 
mesocortical connections) (Grant, 1995; Kandel, Schwartz, & Jessell,
 
1995; Nicholls, Martin, & Wallace, 1992; Phillips, 1984; Routtenberg, 1978;
 
Wise & Rompre, 1989). Although frequently considered together, the
 
mesolimbic-mesocortical systems will be discussed separately to simplify
 
discussion (see Figure 1).
 
Nigrostriatal Fathwav
 
The nigrostriatal system is formed by DA neurons that originate in
 
the substantia nigra and project to several striatal sites, including the
 
caudate-putamen, subthalamic nucleus and the globus pallidus. The rat
 
substantia nigra has 7000 DA cells which contain over 250,000 processes
 
extending into the caudate-putamen (Nicholls et al„ 1992). When the
 
neurons are activated, DA is released at the terminals and mediates the
 
voluntary control of movement (Kandel et al., 1995). Parkinson's disease,
 
which is characterized by muscle rigidity, tremor and difficulty in
 
initiating movement, occurs when the DA cells of the nigrostriatal
 
pathway degenerate (Agid, 1991).
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Mesocortical Pathway
 
The DA eells of the mesocortical system primarily have their origin
 
in the ventral tegmentum (Area 10). Their projections extend to the
 
cerebral cortex where they are thought to contribute to cognition (Kandel
 
et al., 1995; LeDoux, Iwata, Cicchetti, & Reis, 1988). DA fiber projections
 
are most dense in the prefrontal cortex, where the functions of
 
motivation and planning are believed to occur (Fibiger & Phillips, 1986,
 
1988.; Goeders & Smith, 1983).
 
The temporal organization of behavior, attention and social
 
responses may also be modulated by activity in this pathway
 
(Castellanos et al., 1994). Much research indicates that an interaction
 
exists between the cortical and subcortical DA systems, through fiber
 
connections traversing both regions. A reduction in prefrontal DA
 
innervation causes increased activity in subcortical brain areas (Deutch,
 
Clark, & Roth, 1990; Gariano & Groves, 1988; Kandel et al., 1995;
 
Nicholls, 1992). Afferents from the prefrontal cortex are believed to make
 
synaptic connections with dopaminergic structures in the VTA (Deutch
 
et al., 1990). Moreover, prefrontal afferent fibers are in close proximity to
 
tyrosine hydroxylase positive terminals within the mesolimbic pathway
 
(Sesack & Pickel, 1992). This suggests that the cortex and the mesolimbic
 
system do not function in isolation from one another: Drugs that impact
 
one may exert changes on the other.
 
Furthermore, it has also been demonstrated that activation of the
 
prefrontal cortex directly increases dopaminergic activity within non-

cortical DA pathways (Gariano & Groves, 1988; Murase, Mathe, Grenhoff,
 
& Svensson, 1993; Taber & Fibiger, 1993). In contrast, input going from
 
the dopaminergic system to the prefrontal cortex appears to be
 
inhibitory (Jaskiw, Weinberger, & Crawly, 1991; Louilot, LeMoal, & Simon,
 
1989). A reduction in prefrontal dopaminergic activity results in
 
increased activity and/or heightened sensitivity within the mesolimbic
 
region (Deutch et al, 1990; Haroutunian, Kanof, & Davis, 1989; Pycock,
 
Kerwin, & Carter, 1980; Rosin, Clark, Goldstein, Roth, & Deutch, 1992).
 
Mesolimbic Pathwav
 
The mesolimbic system is critically involved in reward. This
 
system is composed of DA cell bodies that are found in the VTA and the
 
axons of these DA neurons extend into the NA and amygdala. Therefore,
 
activation of cell bodies in the VTA results in increased DA release from
 
terminal fibers in the NA and the amygdala (DiChiara & Imperato, 1988;
 
Hiroi & White, 1991b; Phillips, 1984; Routtenberg, 1978; Wise & Rompre,
 
1989). The neural input into the VTA is from the medial forebrain
 
bundle (MFB). When the MFB is stimulated, it excites non-dopaminergic
 
fibers which synapse on DA neurons in the VTA and substantia nigra
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(Shizgal & Murray, 1989) (see Fig^^
 
DA Receptors
 
Following its release from the DA terminal, DA neurotransmitter
 
binds to specific receptor sites (see Figure 3). These receptors are
 
classified according to similarities in genetic Structure and ~the presence
 
of common second messenger mechanisms. One family of DA receptors
 
comprises the Di and D5 subtypes. The Di receptors are found in the
 
mesocortical system. The second family of DA receptors is called D2 and
 
also includes the D3 and D4 types.
 
The DA receptor prominent in the nigrostriatal system is the D2
 
subtype, whereas D3 and D4 receptors are primarily distributed in the
 
mesolimbic system. Presynaptic DA receptors appear to be localized in
 
two main areas: one is on DA cell bodies in the mesolimbic region (called
 
somatodendritic autoreceptors), where they modulate the firing of DA
 
neurons; the second is on DA axonal terminals (called terminal
 
autoreceptors), where they modulate release of DA (Cooper, Bloom, &
 
Roth, 1991; deKeyser, 1993).
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 MESOLIMBIC DOPAMINE SYSTEM
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 Qpioid Structures Within The Mesolimbic system
 
Opioid receptors and natural opioids, called enkephalins and
 
endorphins, are found in abundance within the mesolimbic system
 
(Kalin & Loevinger, 1983; Spanagel, 1995). Binding studies demonstrate
 
that opioid and DA receptors are co-localized in the^ VTA and fibers
 
containing enkephalin are found together with DA neurons (Manzanares,
 
Lookingland, & Moore, 1991; Morel & Pelletier, 1986). Some of the opioid
 
receptor subtypes have been implicated in the mediation of mesolimbic
 
DA functioning (DiChiara & Imperato, 1988; Mansour, Khachaturian,
 
■ ■ ■ . . ' 
Lewis, Akil, & Watson, 1988).
 
Opiate receptor binding sites and their corresponding
 
neurotransmitters are divided into three major subtypes called mu (p.),
 
delta (6) and kappa (k) (Lord, Waterfield, Hughs, & Kosterlitz, 1977).
 
Morphine and met-enkephalin have a high affinity for p receptors,
 
whereas leu-enkephalin preferentially binds to 6 receptors. D-ala-met­
enkephalin, a specific p receptor agonist is found to bind directly to
 
endogenous opiate met-enkephalin p receptors localized in the VTA
 
(Satoh & Minami, 1995). However, mRNA studies have found evidence for
 
the presence of p receptors in both the VTA and the NA (Azaryan,
 
Coughlin, Buzas, & Cox, 1996). High concentrations of the endogenous 6
 
neurotransmitter leu-enkephalin and 6 receptors are also found in the
 
14
 
NA and the VTA (Mansour at aL, 1988; Satoh & Minami, 1995). k
 
receptor sites are located within many brain regions including the NA,
 
VTA, medial prefrontal cortex and lateral hypothalamus (Bals-Kubik,
 
Ableitner, Herz, & Shippenberg, 1993). k receptors are bound by
 
deltrophins and research suggests that they are important-

aversive stimulation (Erspamer et al., 1989).
 
When It receptors are bound by an agonist, they activate DA
 
neurons in the mesolimbic pathway (see Figiire 4). Specifically,
 
activation of those |t receptors located on GABAergic in'temeurons in the
 
VTA inhibits the release of GABA (Brady, Herkenham, Long, & Rothman,
 
1989; La Motte, Snowman, Pert, & Snyder, 1978).
 
These GABA neurons normally inhibit the DA fibers of the
 
mesolimbic pathway, so a lack of GABA activation prevents the
 
inhibition of DA neurons and, indirectly, results in DA activation
 
(DiChiara & North, 1992; Klein et al., 1993). Microdialysis studies
 
indicate that when opiates bind to |i receptors, an activation of
 
mesolimbic DA neurons occurs (DiChiara & Imperato, 1988). Specifically,
 
when morphine is injected exclusively into the VTA, DA neurons are
 
activated causing increases in DA levels within the NA (DiChiara &
 
Imperato, 1988).
 
1,5.-^,
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Morphine enhances DA activity if given either systemically or
 
locally injected into the VTA, but not when morphine is injected directly
 
into the NA. A model describing the modulation of the mesolirhbic
 
system by two opposing opioid systems has been constructed by
 
Spanagel et al. (1992). They propose that the DA neurons projecting to
 
the NA can be disirihibited by p.-opioid feceptors located on those GABA
 
inhibitory interneurons in the VTA (see Figure 4). The disinhibition of
 
the DA neurons causes a measurable increase in NA DA release, which is
 
reflected in behavior (Spanagel et al., 1992). Whereas, the activation of k-

opioid receptors located in the NA results in the inhibition of DA release
 
and has aversive and sedative effects on behavior (Spanagel et al., 1992).
 
In summary, the mesolimbic DA system, whose DA neurons arise in
 
the VTA and extend their axons into the NA, has been implicated in the
 
mediation of reward (Ettenberg, 1989; Wise, 1983; Wise & Rompre^ 1989).
 
p and 6 opioid receptors enhance DA function by disinhibiting the DA
 
neurons of the mesolimbic pathway, whereas k receptors directly inhibit
 
DA release in the NA (DiChiara & North, 1992; Klein et al., 1993; Spanagel
 
et al., 1992).
 
PHARMACOLOGYOFREWARD
 
Animal research suggests that the brain has natural reinforcement
 
mechanisms, with both endogenous DA and opioid processes modulating
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reward (Olds & Milner, 1954; Salamone, Cousins, McCullough, & Carriera,
 
1994; Shizgal & Murray, 1989; Wise, 1983). There is a large amount of
 
evidence that the mesolimbic DA pathway is responsible for the
 
reinforcing effects of natural rewards such as food and water. There is
 
also considerable support for the role played by the DA pathway in the
 
reinforcement properties of addictive drugs. The inost important
 
paradigms assessing reward are the instrumental conditioning, operant
 
conditioning, and CPP paradigms (Ettenberg & Camp, 1986; Hoffman,
 
1989; Wise & Rompre, 1989).
 
DAREWARD
 
Instrumental Conditioning Studies
 
Utilizing the instrumental conditioning paradigm, several
 
laboratories have investigated the reinforcing effects of food and water
 
consumption by challenging DA receptors with antagonists (Ettenberg &
 
Camp, 1986; Ettenberg & Horvitz, 199G; Ettenberg, Koob, & Bloom, 1981;
 
Ljungberg & Ungerstedt, T979). In a study that examined the role of DA
 
in water reward, an experimental group received a pretreatment of either
 
pimozide or haloperidol (DA receptor antagonists). Response times of
 
untreated, water deprived animals was faster when compared to thirsty
 
rats that had been pretreated with DA antagonists (Ettenberg & Camp,
 
1986; Ettenberg & Horvitz, 1990).
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Researchers also used DA antagonists to challenge the reinforcing
 
properties of food reward. Blockade of DA receptors by haloperidol
 
reduced response times and running speeds of rats towards a food
 
reward. Apparently, the reinforcement value of food pellets was
 
effectively suppressed by DA.antagonists, reducing the importance of the
 
anticipated reward (Ettenberg & Camp, 1986). Thus, through DA
 
antagonism, the reinforcement qualities of food and water reward could
 
be attenuated in the runway paradigm (Ettenberg & Camp, 1986;
 
Ettenberg & Horvitz, 1990).
 
Importantly, other researchers have contended that drug-induced
 
motor deficits, rather than reward diminution, could account for the
 
decrease in reinforced responding (Ettenberg, Koob, & Bloom, 1981;
 
Ljungberg & Ungerstedt, 1979). To assess the possibility of a motor
 
confound, experimenters either tested rats in a non-drugged state or
 
utilized an extinction paradigm to confirm that DA antagonism does
 
attenuate reinforced responding. For example, while testing water reward
 
in a non-drugged state, Ettenberg and Horvitz (1990) demonstrated a
 
reduced running speed in thirsty rats. Because the animals were
 
evaluated 24 hours after DA antagonist treatment, it confirmed that the
 
attenuation of the reinforced response was not related to drug-induced
 
motor impairments (Ettenberg & Horvitz, 1990). Other experiments
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utilized the extinction paradigm to verify DA attenuation of food
 
reward. Rats treated intermittently with DA antagonists demonstrated
 
resistance to extinction, despite the presence of continuous food reward
 
(Ettenberg & Camp, 1986; Salamone, 1986). Therefore, when considered
 
together these results suggest that DA antagonists^M reward value
 
of food and water reinforcers.^ ^ :
 
Utilizing the instrumental conditioning paradigm, sevefal
 
researchers attempted to determine which DA receptor subtypes were
 
respoiisible for natural reward (Fowler, Liou, Rusk & Cooper, 1994; Wise,
 
Spindler, DeWit, & Gerber, 1978b). One study found evidence that the
 
mixed D1/D2 antagonists fluphenazine and pimozide, the Di antagonist
 
SCH 23390, and the D2antagonist raclopride all signifioantly blocked the
 
response to food reward (Fowler et al, 1994; Wise, Spindler, DeWit, &
 
Gerber, 1978). These studies suggest that both the Di and D2 receptors
 
are involved in reward.
 
Operant Conditioning Studies
 
Manipulations of the reward pathway by various agonists and/or
 
antagonists has become a useful method for studying reward system
 
functioning (Beninger et al., 1987; Wise, Spindlef, DeWit, & Gerber, 1978).
 
Because animals possess a natural desire to seek food, they readily learn
 
to lever-press to obtain food pellets. Mot surprisingly, the DA antagonist
 
pimozide, which has been used to suppress instrumental conditioned
 
responding, also significantly attenuates operant conditioning for food
 
(Beninger et al., 1987). Recent microdialysis studies confirm the role
 
played by DA in the consummatory responses of food intake. Rats
 
responding at a high rate for food reinforcement show a significant
 
increase in extracellular DA and DA metabolites in the NA (Ettenberg &
 
Camp, 1986; Salamone et al., 1994). Similarly, Kiyatkin and Gratton
 
(1994) found increased NA DA levels shortly after cues were presented
 
that signaled access to the food-lever. DA levels continued to increase as
 
the subjects earned food reward. These DA levels remained high until
 
lever pressing ceased, causing DA to return to basal levels (Kiyatkin &
 
Gratton, 1994).
 
The opefant conditioning paradigm has also been used to examine
 
which DA receptor subtypes are involved in reward functioning. For
 
example, operant conditioning for food reward is blocked by either Di
 
and/or D2 receptor antagonists, indicating that both Di and D2 receptors
 
are involved in reward (Beninger et al., 1987; Nakajima & Baker, 1989).
 
Not surprisingly, injecting the selective Dj DA antagonist SCH 23390 into
 
the NA also results in the inhibition of lever-pressing for food (Beninger et
 
al., 1987). Thus, DA antagonist studies show that the DA system is
 
critically involved in reward and that both the Dj and D2 receptors are
 
21
 
necessary for normal reward functioning.
 
DA Agonists and Qperant Conditioning
 
Much of the work with psychomotor stimulant drugs, such as
 
cocaine and amphetamine, have jprovided evidence that DA systems are
 
involved in mediating the reinforcing properties of those drugs (Pettit,
 
Ettenberg, Bloom, & Koob, 1981; Yokel & Wise, 1976). Rats continue to
 
self-administer cocaine and amphetamine unless a DA antagonist is
 
administered or the DA terminals in the NA are destroyed by toxic lesion
 
(Yokel & Wise, 1976). Although amphetamine- and cocaine-induced
 
reward correlates >vith an increase in extracellular DA in the NA, the
 
mechanisms of these drugs appear to differ (DiChiara & Imperato, 1988;
 
Ritz, Lamb, Goldberg, & Kuhar, 1987). Specifically, cocaine increases DA
 
levels by blocking DA reuptake (DiChiara & North, 1992; Ritz et al., 1987;
 
Svingos, Strecker, McNeish, & Hitzemann, 1991), whereas amphetamine
 
increases DA release from the terminal fibers (DiChiara & Imperato,
 
1988).
 
Recently, Di receptors located in the NA have been directly
 
implicated in the reinforcing effects of cocaine. Rats were given localized
 
NA injections of a selective Di antagonist to evaluate DA involvement in
 
the reinforcing properties of cocaine. The antagonism of this receptor
 
caused significant increases in cocaine self-administration, which
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suggests that Di receptors in the NA modulate cocaine self-

administration (Maldonado, Robledo, Chovef, & Caihe, 1993). Curiously,
 
Calcagnetti et al. (1995) have found thm ndn--dopaminergic receptor
 
antagonists can successfully attenuate cocaine's actions. They include
 
calcium channel blockers, 5-HT3 antagonists, and Opiate antagonists.
 
There is much speculation about the underlying mechanisms by which
 
these drugs attenuate cocaine's actions. One possibility is that these
 
drugs regulate ion flow through neuronal membrane channels
 
(Calcagnetti et aL, 1995; Menkens et aL, 1992). For example, calcium
 
blockade itself causes an attenuation in DA levels (Martellota, Kuzmin,
 
Muglia, Gessa, & Fratto, 1994).
 
In summary, 0perant conditioning studies provide excellent
 
evidence of DA's role in reward. DA antagohists significantly attenuate
 
operant conditioning for reward (Beninger et al., 1987; Wise, Spindler,
 
DeWit, & Gerber, 1978). Microdialysis and electrochemical examination
 
of mesolimbic DA activity also supports DA's involvement in conditioned
 
behaviors (Ettenberg & Camp, 1986; Kiyalkin & Gratt^^ 1994; Salamone
 
et al., 1994), Although there is some disagreement as to the exact DA
 
subtypes involved in reward, most agree that both Di and D2 receptors
 
are necessary for its expression (Beninger et al., 1987; Nakajima & Baker,
 
1989; Phillips et^ a^^^^^
 
CPP
 
Along with instrumental eonditioning and operant conditioning
 
studies, CPP experiments implicate the mesolimbic DA system in drug-

induced reward. Although instrumental conditioning and operant
 
studies have provided considerable amounts of information on the
 
neural substrates involved in reward, the disadvantage of these
 
procedures is that animals must perform complex maneuvers while still
 
under the influence of the drug (Ettenberg, 1989). The CPP paradigm
 
eliminates this problem because conditioned animals are in a non-

drugged State during testing (Bozarth, 1987; Schecter & Calcagnetti,
 
1993).
 
In the CPP paradigm rats are given a drug and confined to one side
 
of a two compartment chamber (these compartments are visually and
 
tactilly distinct). On the subsequent day the same rat is given saline and
 
confined in the opposite chamber. After a number of trials, the animal is
 
tested in the drug free state and their compartment preference is
 
assessed. This paradigm eliminates the possible interference of motor
 
effects caused by testing in the drug-induced state (Schecter &
 
Calcagnetti, 1993). Evidence indicates that CPP can be established in rats
 
by Systemic injections of cocaine, amphetamine, and morphine. This
 
reinforced behavior can be blocked by haloperidol and reduced by 6­
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OHDA lesions (Hawkins & Stein, 1991; Reicher & Holntah, 1977; Sherman,
 
Roberts, Roskam; & Holman, 1980; Spyraki, Fibiger, & PM 1982a; Wise
 
& Rompre, 1989). Studies have also shown that DA neurotransmission is
 
essential for the establishment of the reinforcing properties of food
 
reward, as well as the addictive qualities of Substances of abuse'(Be
 
et al., 1987; Fibiger & Phillips, 1982; Wise, Spindler, & Legault, 1978; Wise
 
& Bozarth, 1987).
 
Evidence indicates that reward is actually two separate processes
 
that are controlled by, and function differently within the mesolimbm
 
system (Hiroi & White, 1991a, 1991b; White & Carr, 1984, 1995). The
 
acquisition and expression of reward behaviors are mediated bydifferent
 
receptor mechanisms (Hiroi & White, 1989; 1990, 1991a; Spyraki, Fibiger,
 
& Phillips, 1982a; White & Carr, 1984, 1985). The acquisition of a CPP
 
involves the pairing of environmental stimuli with drug-induced
 
mesdlimbic DA Whereas, the expression of a previously
 
established CPP can be activated by conditioned stimuli, which are
 
originally paired with events that had evoked the unconditioned release
 
of DA. These two mechanisms (i.e., acquisition and expression) are
 
dissociable. For example, acquisition and expression can be individually
 
blocked by antagonists of different DA recpptor subtypes (White & Carr,
 
1984, 1985). The acquisition of CPP appears to be dependent upon
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activation of DA neurons within the VTA, resulting in DA release in the
 
NA. Microinjections of DA agonists in this area results in CPP acquisition,
 
and it is attenuated by the depletion of DA within the NA
 
(DiChiara & Imperato, 1988; Spyraki et al.,1982b). Studies of the
 
expression of a previously established drug-induced CPP demonstrate
 
that it can be blocked through the systemic, or NA injection of DA
 
antagonists (Hiroi and White, 1989, 1990; Spyraki et al., 1982b). When
 
selective DA antagonists are injected following conditioning trials, the
 
expression of CPP on the drug-free test day is effectively blocked (Hiroi &
 
White, 1991a, 1991b).
 
More specifically, when conditioned stimuli (i.e., a scented or
 
visually distinct chamber) are paired with an unconditioned stimulus
 
(i.e., the DA release caused by the addictive drug), the conditioned
 
stimuli eventually acquire the property of evoking DA neuronal
 
activation. Thus, when the animal encounters conditioned stimuli in the
 
absence of the drug, an elevation of DA metabolism is observed in the
 
terminal area of the mesolimbic system (Hiroi & White, 1990, 1991a).
 
This is thought to be the expression of the conditioned response.
 
Evidence suggests that Di receptors located in the NA mediate the
 
expression of CPP behavior (Hiroi & White, 1991a; White, Packard, &
 
Hiroi, 1991). In contrast, evidence indicates that D2 receptors in the NA
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mediates the aequisition of the uncoiiditioned effects of the addictive
 
drug (Hiroi, McDonald, & White, 1990; Hiroi & White, 1989, 1990, 199la,
 
1991b). This possibly explains why DA release is still observed when rats
 
are given D2 antagonists after cocaine and amphetamine treatment
 
(Hiroi & White, 1991a; Ritz et al, 1987). The Di mediated conditioned
 
reinforcers are not blunted by D2 antagonists.
 
Further evidence suggests that the expression of conditioned
 
behavior is also mediated through intrinsic neurons of the lateral
 
nucleus of the amygdala, because NMDA toxic or electrolytic lesions
 
made to this region attenuates amphetamine-induced CPP (Hiroi &
 
White, 1991b). Afferents that target the NA project from the amygdala,
 
hippocampus, entorhinal cortex, and the cerebral cortex (among others)
 
(Kelley, DomesiCk, & Nauta, 1982; Phillipson & Griffiths, 1985; Sorenseh &
 
Witter, 1983) (see Figure 1 and 3). However, it is the amygdala and
 
hippocampus that have been specifically implicated in memory, and
 
lesions to these two regions cause deficits in several types of memory
 
tasks (Peinado-Manzano, 1990; Sutherland & McDonald, 1990). In fact,
 
Hiroi and White (1991) discovered that expression of amphetamine-

induced CPP is mediated by intrinsic neurons of the lateral nucleus of
 
the amygdala, since their destruction effectively prevents the expression
 
of GPP reward (Hiroi & White, 1991b). This suggests that DA afferents
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connecting the lateral nuciens of the amygdala and the NA, are
 
responsible for the expression of CPP. Furthermore, 5-HT3 receptors
 
localized to the airiygdala have recently been implicated in the
 
modulation of reward (Dyr & Kostowski, 1995).
 
Although both the acquisition and expression of conditioned
 
behaviors are mediated by DA receptor activation, different subtypes
 
modulate these mechanisms (Hirbi & White, 1989, 1990; Spyraki, Fibiger,
 
& Phillips, 1982a; White & Carr, 1984, 1985). Studies have demohstrated
 
that the drug-induced acquisition of CPP can be attenuated when D2
 
antagonists are given prior to the DA agonist during conditioning
 
sessions. This inhibits the acquisition of GPP, as demonstrated by the rat
 
showing no preference behavior on the drug-free test day (Hiroi & White,
 
1989; Spyraki, Fibiger, & Phillips, 1982a). Surprisingly, the acquisition of
 
amphetamine-induced CPP can be initiated by the injection of selective
 
agonists of either Di or D2 receptors located within the NA. When
 
antagonists of either subtype are injected before conditioning, the
 
acquisition of CPP is blocked (Hoffman & Beninger, 1989; Leone &
 
DiChiara, 1987; Spyraki, Fibiger, & Phillips, 1982a) (see Figure 5). In
 
contrast, the expression of previously established CPP can be inhibited by
 
systemic or intracranial NA injections of Di antagonists just prior to the
 
drug-free test trial.
 
BLOGJ^ING ACQUISITION
 
DA Antagonist Is Given Dufing Morpliine- Or
 
Cocaine-induced Conditioned Place Preference(CPP)
 
Injection of
 
da Antagonist
 
CPP Acquisition
 
Is Blocked
 
BLOCKING EXPRESSION
DA Antagonist Is Given After Morpbine- or Cocaine-induced
 
Conditioned Place Preference(CPP)
 
Ezpression
 
Is Blocked
 
injection of
 
A Antagonist
 
BLOCKADE OF THE ACQUISITION OR EXPRESSION OF CPP
 
Figure 5 Blockade Of CPP Acquisition Or Expression.
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Furthermore, evidence indicates that antagonists of the D2 receptor
 
subtype are unable to block the expression of drug-induced CPP when
 
injected following conditioning. Only antagonists of the Di receptor can
 
prevent the expression of a previously established amphetamine-induced
 
CPP (Hiroi «& White, 1991).
 
The acquisition of CPP by cocaine has shown a similar complexity
 
of action. Although cocaine-induced CPP can be blocked by the DA
 
antagonist pimozide, it appears that the neural mechanisms mediating
 
cocaine-induced CPP are complicated (deWit & Wise, 1978; Goeders &
 
Smith, 1983). For example, some neuroleptics have no effect on the
 
acquisition or expression of cocaine-induced CPP.
 
More specifically, haloperidol does not block cocaine-induced CPP
 
except at very high doses, whereas low doses of haloperidol attenuate
 
amphetamine-induced CPP (Hawkins & Stein, 1991; Spyraki, Fibiger, &
 
Phillips, 1982b; Wise & Rompre, 1989). Furthermore, lesions to DA
 
neurons in the NA blocks cocaine self-administration, but not cocaine-

induced CPP (Dworkin, Guerin, Goeders, & Smith, 1988; Spyraki, Fibiger,
 
& Phillips, 1982b).
 
In summary, CPP is an excellent paradigm for evaluating reward
 
processes (Bozarth, 1987; Schecter & Calcagnetti, 1993). Drugs that
 
increase DA levels, such as cocaine and amphetamine, induce the
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acquisition and expression of GPP. Antagonists of either the Pi or the Da
 
receptor attenuate the acquisition of CPP, but only Di receptor
 
antagonists attenuate the expression of CPP (Hawkins & Stein, 1991; Hiroi
 
& White, 1991a; Leone & DiChiara, 1987; Reicher & Holman, 1977;
 
Sherman et al., 1980; Spyraki, Fibiger, & Phillips, 1982a; Spyraki, Fibiger,
 
& Phillips, 1982b; Wise & Rompre, 1989). Thus, two dissociable processes
 
(i.e., acquisition and expression) are important for place preference
 
conditioning; however, it appears that both of these processes are
 
mediated by dissociable DA systems.
 
OPIOIDREWARD
 
Operant conditioning and CPP studies also indicate the presence of
 
a mesolimbic opioid system. Research indicates that a tonically active
 
endogenous opioid system modulates the basal activity of mesolimbic
 
DA neurons and, in this way, the opioid system has a marked effect on
 
conditioned behaviors. Opiate-induced reward can be attenuated by DA
 
receptor antagonists such as SCH 23390 and eticlopride, as well as the
 
opioid antagonists naloxone and naltrindole (Bozarth, 1987; Bozarth &
 
Wise; 1981; Hawkins & Stein, 1991; Phillips et al., 1991).
 
Operant Conditioning Studies
 
The operant conditioning paradigm has provided evidence that
 
opioid receptors have a role in DA reward processes. The reinforced
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respGnding induced by morphine self-administration increases DA within
 
the NA (Shippenberg et al., 1993). Moreover, recent electrochemical
 
techniques suggest that p-opioid activation within the VTA results in a
 
dose-dependent increase in DA electrochemical signaling (Noel &
 
Gratton, 1995).
 
The infusion of morphine directly into the VTA causes rats to self-

administer increasing doses of the drug, as evidenced by a more rapid
 
bar-pressing rate (Olds, 1992). This illustrates that the rewarding
 
properties of morphine, as reflected in increased self-administration
 
behayior, are due to activation of DA neurons in the VTA (Bozarth,
 
1987). Additionally, Rompre and Wise (1988) demonstrated specifically
 
that A10 VTA DA neurons are activated by morphine. They implanted
 
electrodes that allowed rats to self-administer electrical stimulation to
 
AlO neurons. Systemically injected pimozide increased the threshold for
 
self-stimulation, while morphine injected into the VTA reversed the
 
effects of pimozide, causing animals to revert back to the previous
 
pattern of self-stimulation. Naloxone blocked the reversal effects of
 
morphine and the GABA agonist muscimol reinstated self-stimulation
 
behavior, apparently because rats were motivated to increase morphine
 
reinforcement (Rompre & Wise, 1988). This operant conditioning study
 
again indicates that DA cells in the VTA are important for reward and
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suggests that DA is involved in morphine^nduced reward. The study also
 
points to the role GABA receptors play m niorphine-induced reward by
 
demonstrating that a GABA agonist can block morpliine's actions
 
(Rompre & Wise, 1988).
 
CPP
 
GPP studies also show that the endogenous opioid system is
 
involved in reward. CPP can be induced by injecting D-ala-met­
enkephalin (a specific p. receptor agonist) directly into the VTA.
 
Importantly, microdialysis has shown that this causes a concurrent
 
increase in extracellular DA within the NA. Pretreatment with an opiate
 
antagonist, such as naloxone or naltrindole, attenuates opiate-induced
 
CPP, while at the same time suppressing DA levels in the NA (Barr & Rossi,
 
1992; Bozarth & Wise, 1980; DiChiara & North, 1992; Hawkins & Stein,
 
1991; Suzuki, Tsuji, Mori, & Misawa, 1995). This implicates the
 
endogenous opioid system in reward and suggests that it is located
 
within the VTA. k opioid subtypes are also involved in reward, since
 
activation of k opioid receptors attenuates responding for morphine
 
(Mucha & Herz, 1985; Suzuki et al., 1995). Specifically, pretreatment
 
with the k agonist U-50,488H blocks the normal accumulation of
 
morphine-induced DA in the NA, while completely abolishing morphine-

induced CPP (Mucha & Herz, 1985). When taken together, these studies
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indicate that stimulation of |i receptors activates DA neurons, while k
 
receptor stimulation inhibits DA neurotransmission.
 
In summary, examination of the neurochemical mechanisms of
 
reward indicates that an endogenous DA reward system mediates the
 
rewarding properties of food and water. The endogenous opioids are also
 
involved in reward, apparently by activating the DA reward system.
 
Instrumental conditioning, operant conditioning and CPP studies have
 
shown that both an endogenous DA and opioid system are components
 
of the reward pathway.
 
SEROTONINSTRUCTUREANDFUNCTION
 
Surprisingly, evidence supports the concept that the reward system
 
can be modified by experimental changes in serotonin neurotransmisson
 
(Bilsky & Reid, 1991; Carboni, Acquas, Frau, & DiChiara, 1989; Carboni,
 
Acquas, Leone, Perezzani, & DiChiara, 1988; Higgins, Joharchi, Nguyen, &
 
Sellars, 1992; Imperato & Angelluci, 1989). Therefore, an examination of
 
serotonin neurobiology will be followed by studies assessing interactions
 
between DA and serotonin systems within the reward process.
 
Serotonin Pathwavs
 
The connections made by serotonin neuronal processes throughout
 
the brain indicates its potential to modulate DA neurotransmission.
 
Serotonin axons innervate many of the same regions of the CNS where DA
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pathways are found (Jacobs & Azmitia, 1992). Passing through the
 
medial forebrain bundleV serotonin pfojections reach tnany rostral sites
 
including the striatum, limbic structures, diencephalon and the cerebral
 
cortex (Jacobs & Azmita, 1992; Shizgal <& Murray, 1989) (see Figure 6 and
 
1). ■ . ; / '' 
Although outnumbering noradrenergic and DA cells, serotonin cell
 
bodies are localized to a few nuclei in the brain stem (Lauder & Bloom,
 
1975). Serotonergic neurons arise from distinct nuclei called the dorsal
 
raphe and median raphe. Raphe nuclei lay directly along the midline of
 
the brainstem from the medulla to the midbrain and their fibers have
 
both ascending and descending pathways (Lauder & Bloom, 1975;
 
Nicholls et al., 1992; Steinbusch, 1984). Projecting to the medulla,
 
descending fibers are believed to modulute spinal sensory and motor
 
neurons, and are involved in regulating motor movenients as well as in
 
the perception of pain (Parent, Descarries; & Beaudet, 1981). This
 
apparently is the reason that application of a serotonin agonist causes
 
excitability of motor pathways.
 
Studies of ascending fibers indicate tbat raphe nuclei in the pons
 
and midbrain innervate the entire brain, projecting from the locus
 
coerleus to forrn part of the ascending reticular activating system.
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Figure 7 Serotonin Pathways: Lateral View.
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Thus, 5-HT neurons have been implieated Tn the sleep-wake cycle,
 
through the naodulation of locus coerleus functioning and possibly other
 
unknown rnechanisnis (Steinbusch, 1984).
 
The intraventricular administration of the serotonin ttacer i3H]-5i
 
hydroxytryptamine shows that ascending serotonin axons pass next to
 
DA neurons (Parent ef aLy 1981). Sirnilarly^ serotonin-like cells and fibers
 
are found in close proximity to AlO DA neurons in the VTA, indicating
 
that mesolimbic DA neurons within the AlO area of the tegmentum
 
appear to be innervated by serotonergic axons projecting from thp
 
pontine raphe (Halliday & Tork, 1989) (see Figure 8);
 
Serotonin Receptors: Distribution And Function
 
Researchers have attempted to detail the distribution of serotonin
 
receptors through assays of genetic material immunoreactiye analysis
 
and radiographic bindihg studies. Serotonin mRNA has been found in the
 
NA, striatum, tegmentum, spinal cord, baSal forebrain, nucleus basalis,
 
olfactory tubdrcle and Cerebral cortex (Johnson & Heineniann, 1995).
 
Released from the terminal, serotonin neurotransmitter binds to its
 
receptor binding site (see Figure 9).
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Figure 9. Serotonin Receptor Model.
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Serotonin receptors are grouped into three basic families according
 
to structure and second messenger system properties: 1) the 5-HTi family
 
includes 5-HTia, 5-HTid, 5-HTie and 5-HTif, which utilize G-protein­
mediated signal transduction; 2) the S-HTi family includes 5-HT2a, 5­
HT2B. 5-HT2C and 5-HT4, which use phosphoinositol-mediated signal
 
transduction; 3) the 5-HT3 receptor which controls an ion-gated channel
 
for signal transduction (Dubovsky & Thomas, 1995) (see Figure 10).
 
Specifically, somatodendritic serotonergic autoreceptors of mainly the 5­
HTia type are found on serotonin neurons in the raphe nucleus ^ nd
 
function to modulate firing of serotonergic neurons (Jacobs & Azmitia,
 
1992).
 
Autoreceptors located on terminals are of the 5-HTid variety, and
 
they modulate release of neurotransmitter from serotonergic terminals
 
(BoeSs & Martin, 1994). Serotonin receptors located in the mesolimbic
 
area include the 5-HTiA and 5-HT3 subtypes (Barnes, Barnes, Costall,
 
Ironside, & Naylor, 1989; Boess & Martin, 1994; Jacobs & Azmitia, 1992).
 
Evidence implicates 5-HT3 receptors in a presynaptic role, both in
 
the peripheral nervous system (PNS) and the central nervous system
 
(CNS). Besides being localized to presynaptic sites on fibers and terminals
 
in the PNS, research suggests that the 5-HT3 receptors are also located on
 
axons at synaptic terminals in regions of the mesolimbip^ nueleus tractus
 
41
 
solitarius, and medulla dhlongota (Barnes, Bames, Costall, Ironside, &
 
Naylor, 1989; Kidd et al., 1993; Lapdrte et al., 1992). Impdrtantly,
 
autdradidgraphic studies have fdund that 5-HT3 receptdrs appear td
 
reside dn fibers which prdject frdm serdtdhin cell bddies clustered in
 
raphe nuclei. These fibers appear td pass near DA cells located in the
 
midbrain (Barnes, Barnes, Cdstall, Ironside, & Naylor, 1989; Kidd et al.,
 
1993) (see Figure 1). Biochemical, electrophysidldgical and behavioral
 
studies indicate that 5-HT3 ;reCeptdrs modulate the release of DA,
 
serotonin, norepinephrine, acetylchdline and cholecystokinin (Barnes,
 
Barnes, Costall, Naylor, & Tyers, 1989; Blandina, Goldfarb, Craddock-

Royal, & Green, 1989; Grant, 1995).
 
The; highest density of 5-Ht3 mRNA sequences and receptor binding
 
is found in the nucleus tractus solitarius, dorsal motor nucleus of the
 
vagus nerve, area postrema, spinal tract of the trigeminal nerve, and on
 
all parts of the medulla oblongota (Cohen, T990; Kilpatrick, Jones, &
 
Tyers, 1988).
 
PCR amplification of mRNA 5-HT3 sequences also indicates the
 
presence of the 5-HT3 receptor in the rat NA and VTA, and transcripts
 
were detected in mouse embryo tegmentum as early as day 14 of
 
gestation (Johnson & Heinemann, 1995; Maricq, Peterson, Brake, Myers, &
 
Julius, 1991). Autoradiographic studies of the mesolimbic region appear
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to confirm the presence of 5-HT3receptors in the NA and VTA. However,
 
they are most dense in entorhinal cortex, hippocampus and amygdala,
 
where it is believed that they exert their effects on cognition, anxiety,
 
depression, psychotic symptoms, arid the expression of reward (Boess &
 
Martin, 1994; Hiroi «& White, 1991b; Johnson & Heinemann, 1995; Maricq
 
et al., 1991).
 
In summary, autoradiographic and mRNA evidence supports the
 
close proximity of 5-HT3 receptors to the DA reward pathway. Its
 
presynaptic location and ligand-gating properties suggests a functional
 
role in neurotransmitter release. Because this receptor is found both
 
peripherally and in many regions of brain, systemic injection of 5-HT3
 
agonists and antagonists have the potential of affecting not only the
 
mesolimbic system but other systems as well.
 
DA ANDSEROTONININTERACTIONS
 
Evidence supports the concept that serotonin receptors are
 
important in rnodulating DA levels and release characteristics within the
 
mesolimbic system (Carboni, Acquas, Frau, & DiChiara, 1989; Costall et
 
al., 1976). When a serotonin agonist is given systeinically, measurable
 
increases of DA occur in the NA (Blandina et al., 1989; Blandina,
 
Goldfarb, & Green, 1988; Jiang, Ashby, Kasser, & Wang, 1990; Yi, Gifford,
 
& Johnson, 1991). In cbntrast, systemically injected 5-HT3 antagonists
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attenuate DA and serotonin agonist-induced increases of DA in the NA
 
(Costall, Hui, & Naylor,1979; Hagan et al., 1987; Imperato et al., 1992).
 
Conversely, DA levels appear to regulate serotonin release.
 
Serotonergic projections extending from serotonin cell bodies in the
 
raphe nuclei, pass near dopaminergic cells clustered in the- A10 region of
 
the mesolimbic system. These serotonergic cells respond to changes in DA
 
levels by adjusting the amounts of serotonin neurotransmitter they
 
release (Barnes, Barnes, Costall, Ironside, & Naylor, 1989; Kandel et al.,
 
1995; Kidd et al., 1993). Thus, the amount of DA in the VTA appears to
 
be important in regulating serotonin production and release and, in
 
turn, serotonin appears to regulate DA levels (Costall et al, 1987; Perry,
 
Kostrzewa, & Fuller, 1995).
 
Experimentation on one of the earliest 5-HT3 antagonists
 
demonstrated that it produced inhibiting effects on DA agonist-induced
 
reward behaviors in rats (Costall et al., 1987). Called ondansetron, this 5­
HT3 receptor antagonist inhibits amphetamine-induced locomotor
 
activity. The attenuation of DA activation was achieved only when the
 
5-HT3 antagonist was injected systemically or directly into the VTA and
 
had no effect when localized injections were applied directly to the NA
 
(Costall et al., 1979; Imperato & Angelucci, 1989). These studies caused
 
heightened interest in the 5-HT3 receptor and created a proliferation of
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research on the role of 5-HT3 receptors in modulating DA
 
neurotransmission and reward (Acquas, Carboni, Grarau, & DiChiara,
 
1990; Bilsky & Reid 1991; Carboni, Acquas, Frau, & DiChiara, 1989;
 
Carboni, Acquas, Leone, & DiChiara, 1989; Suzuki et al., 1992).
 
DA and Serotonin Interaction: Receptors
 
Evidence suggests that the serotonin receptor has a vital role in
 
modulating DA functioning in the mesolimbic system. Serotonin agonists
 
activate DA neurons in the VTA, resulting in increased DA within the NA,
 
whereas antagonists attenuate these agonist-induced increases (Costall et
 
al., 1987; Imperato & Angelucci, 1989; Invernizzi et al., 1995). Although
 
serotonin antagonists attenuate the enhanced DA levels produced by DA
 
and serotonin agonists, these antagonists have no effect on basal levels of
 
DA (Costall et al., 1987; Invernizzi et al., 1995). This implies that
 
serotonin functions in a "homeostasis-like" role to regulate DA levels in
 
the mesolimbic system (Carboni, Acquas, Frau, & DiChiara, 1989; Costall
 
et al., 1987; Imperato & Angelucci, 1989; Invernizzi et al., 1995; Pel,
 
Zetterstrom, Leslie, & Grahame-Smith, 1993).
 
Cellular studies confirm the impact that 5-HT3 agonists and
 
antagonists have on the DA neuron. When applied to brain slices
 
containing DA cells, the 5-HT3 agonist 2-methylserotonin causes
 
increased DA release that is blocked by the 5-HT3 antagonist tropisetron
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(Blandina et al., 1988, 1989). Although, 5-HT3 agonists increase DA
 
release, and 5-HT3 antagonists block release, the mechanisms mediating
 
these effects remain uncertain (Carboni, Acquas, Frau, & DiChiara, 1989;
 
Costall et al., 1976; Gifford & Wang, 1994; Imperato & Angelucci, 1989).
 
There are several possibilities: that 5-HT3 drugs affect the DA transporter
 
system, that 5-HT3 receptors modulate DA neurons through receptors
 
located near GABAergic interneufons, or that 5-HT3 drugs directly bind to
 
5-HT3 receptors located on DA terminals, which act to modulate DA
 
release (Boess & Martin, 1994; Costall & Naylor, 1992; Klein et al., 1993;
 
Yi et al., 1991).
 
First, evidence indicates that serotonin agonists may affect DA
 
levels by binding to serotonin receptors, resulting in the modulation of
 
the reuptake of DA into the presynaptic neuron. There is also an
 
implication that 5-HT3 receptors may block DA reuptake (Yi et al., 1991)
 
(see Figure 11).
 
Although binding studies demonstrate the presence of 5-HT3
 
receptors in the striatum and NA, direct injections of serotonin
 
antagonists into these regions have no effect on DA content (Imperato &
 
Angelucci, 1989; Yi et al., 1991). When a 5-HT3 receptor agonist is applied
 
to rat striatal cells, it induces DA release in synaptosomes, as well as a
 
Ca++-evoked efflux.
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Both of these effects can be antagonized by the selective DA uptake
 
inhibitors nomifensine and cocaine. This implies that serotonin induces
 
the release of DA from striatal cells by modulating DA reuptake into the
 
DA terminal (Yi et al., 1991). Curiously, when a 5-HT3 antagonist is
 
applied to striatal cells, or is locally injected into striatum, there is no
 
attenuation in the DA release produced by 5-HT3 agonists (Costal et al.,
 
1987; Yi et al., 1991). This suggests that action on the DA reuptake
 
transporter may not be responsible for the actions of these serotonin
 
drugs (see Figure 12).
 
Second, the possibility remains that 5-HT3 antagonists affect DA
 
release by modulating GABA interneurons located in the VTA (Klein et
 
al., 1993) (see Figure 13). For instance, Imperato and Angelucci (1989)
 
demonstrated that the direct perfusion of 5-HT3 antagonists into the NA
 
had no effect on morphine's actions. To attenuate this drug-induced
 
increase in DA, 5-HT3 antagonists must be injected systemically or
 
directly into the VTA where GABA interneurons can affect DA release
 
(Imperato & Angelucci, 1989; Roth, 1994).
 
The third possibility is that activation of 5-HT3 receptors, perhaps
 
located on DA processes, may directly modulate DA release. mRNA and
 
autoradiography studies suggest that 5^HT3 receptors are present in both
 
the NA and VTA.
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 Therefore, the possibility exists that S-HTj agonists or antagonists
 
are capable of directly affecting DA release by modulating presynaptic or
 
postsynaptic sites on dopamine processes (Boess & Martin, 1994; Carboni,
 
Acquas, Leone, & DiChiara, 19S9; Leone & DiChiara, 1987; Roth, 1994; Yi
 
et aL, 1991).
 
If it is the 5-HT3 receptor that is directly affected by 5-HT3 drugs,
 
then two questions still remain: 1) do these receptors reside on serotonin
 
terminals projecting into the VTA or the NA, or 2) do other neurons or
 
their processes contain these 5-HT3 receptors. Serotonin antagonists and
 
addictive drugs are being used to resolve these questions. They are
 
capable of dissociating the mechanisms of the DA reward system.
 
However, much remains to be learned. Although the rewarding effects of
 
cocaine can be attenuated by 5-HT3 ahtagonists, the receptor
 
mechanisms responsible for this antagonism appear to be different than
 
for other addictive drugs (Di Chiara & North, 1992). Microdialysis studies
 
have suggested that while serotonin ahtagonists inhibit cocaine-induced
 
CPP, DA levels remain unchanged in the NA (Svingos et al., 1991), Some
 
believe that the serotonin antagonist's affinity for binding with 5-HT
 
receptors may simply allow them to competitively displace cocaine.
 
Successful attenuation by 5-HT3 antagonism of cocaine-induced CPP can
 
be accomplished when 10-fold doses are used, yet DA content remains
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unchanged in the NA. This implies cocaine's actions may be mediated by
 
other brain regions (Gifford & Wang, 1994; Paris & Cunningham, 1993;
 
Peltier & Schenk, 1991).
 
Cellular studies have produced a different understanding of
 
cocaine's action on the 5-HT receptor. Utilizing patch-clamp techniques
 
on nodose ganglion cells, evidence demonstrates that the application of
 
5-HT (5-hydroxytryptamine) produces a fast inward current. When the 5­
HTs antagonist MDL-72222 is pre-applied to the tissue, a blockade of this
 
inward current is observed (Fan, Visentin, & Weight, 1994). The selective
 
5-HT3 agonist 2-methyl-5-HT reinstates this inward current. When
 
cocaine alone is applied, it has no effect on membrane current, but if
 
cocaine and 5-HT are applied together, the serotonin-induced peak and
 
steady-state current are reduced. If cocaine is pre-applied to the tissue
 
before the 5-HT agonist, the peak and steady-state current is further
 
depressed by cocaine. This suggests that cocaine inhibits 5-HT3 receptor-

mediated inward current (Fan et al., 1994; Lambert et al., 1989; Vanner
 
& Surprenant, 1990). It also implies that some of cocaine's action may
 
result from its competitive antagonism of 5-HT3 receptors, resulting in a
 
blockade of serotonin action.
 
In contrast to cocaine studies, experimental research has provided
 
a clear understanding of the mechanisms in 5-HT3 receptor antagonism
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 of morphine-induced reward. The prerequisite for the expression of
 
morphine reward is the stimulation of DA release in the NA. Therefore, if
 
5-HT3 antagonists can suppress drug-induced increases in DA, it supports
 
a role for the serotonin receptor in the expression of the reward system
 
(Imperato & AngeluCci, 1989). Systemic injections of many 5-HT3
 
antagonists, such as MDL-72222, ICS205-930 and ondansetron, cause a
 
full or partial blockade of mOrphine-induced DA release in the NA
 
(Carboni, Acquas, Leone, & DiChiara, 1989; Imperato & Angelucci, 1989;
 
Pei et al., 1993). Similarly, direct injections into the VTA of ICS205-930,
 
causes a reversal of the morphine-induced DA release in the NA
 
(Imperato & Angelucci, 1989).
 
In summary, although evidence suggests that many 5-HT3 agonists
 
increase DA release in the NA (an action blocked by 5-HT3 antagonists)
 
the exact receptors mediating the DA/serotonin interactions remain
 
uncertain (Carboni, Acquas, Frau, & DiChiara, 1989; Costall et al., 1976,
 
Gifford & Wang, 1994; Imperato & Angelucci, 1989). Research has also
 
shown that 5-HT3 receptor antagonists are capable of attenuating
 
morphine- and cocaine-induCed reward (Carboni, Acquas, Leone, &
 
DiChiara, 1989; Imperato & Angelucci, 1989; Pei et al., 1993).
 
DA and Semtnnin Interaction: Rat Behavior
 
Behavioral studies utilizing injections of serotonin agonists and
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antagonists have resulted in a greater understanding of the serotonin
 
receptor's role in the DA reward pathway (Carboni, Acquas, Leone, &
 
DiChiara, 1989, Carboni, Acquas, Frau, & DiChiara, 1989; Imperato &
 
Angelucci, 1989; Suzuki et al., 1992). However, little is known about the
 
involvement of serotonin receptors in the expression of reward. Most
 
studies have tested only the acquisition of reinforced behavior (Acquas et
 
al., 1990; Carboni et al., 1988; Higgens et al., 1992; Pei et al., 1993).
 
Overall, acquisition of cocaine- and morphine-induced conditioned
 
behaviors is blocked by antagonists of the S-HTg receptor, while these
 
antagonists fail to affect cocaine self-administration and stimulus
 
discrimination (Borg & Taylor 1994; Culcagnetti et al., 1995, Curbpni et
 
al, 1988; Higgins et al.,/ 1992; Joharchi et al., 1993; Martellota et aL,
 
1994; Pei et al, 1993; Svingos & Hitzemanh- 1992). For example, systeinic
 
injection of S-HTs antagbnists decrease cocaine-induced locomotion
 
(Reith, 1990; Svingos & Hitzemann, 1992). Acquisition of cocaine-induced
 
CPP was also attenuated by systemic treatment with 5-HT3 antagonists
 
(Suzuki et al, 1992; Svingos & Hitzemann, 1992). In contrast, S-HT^
 
antagonists only appear to block the locomotor activity produced by
 
chronic, but not acute, cocaine treatment (King et al., 1994).
 
Along with blockihg many cocaine-induced behaviors, 5-HT3
 
antagonists attenuate morphine-induced responses in rats (Acquas et al.,
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1990; Bilsky & Reid, 1991; Borg & Taylor 1994; Carboni et al., 1988;
 
Higgins et al., 1992; Joharchi at al., 1993; Pel et al., 1993; Suzuki et al.,
 
1992). S-HTs antagonists not only inhibit certain conditioned behaviors,
 
they attenuate morphine-induced DA increases in the NA. Consistent
 
with this finding, S-HTs antagonists attenuate morphine-induced CP?
 
and locomotion (Carboni et al., 1988; Higgins et al., 1992; Pei et al.,
 
1993). Interestingly, MDL-72222 and ondansetron were unable to block
 
morphine self-administration (similar results were obtained with
 
cocaine) (Borg & Taylor, 1994; Higgins et al., 1992). This suggests that
 
regional specificity of drug effects may be involved in different behaviors
 
(Svingos & Hitzemann, 1992).
 
In summary, studies examining the biochemical and behavioral
 
actions of addictive drugs demonstrate that they produce reward by
 
activating the mesolimbic DA system. The blockade of morphine- and
 
cOcaine-induced reward by antagonists of the S-HTj receptor, clearly
 
imply that this receptor is involved in the expression of reward. In
 
addition, evidence has suggested that the biochemical consequences of 5­
HT3 antagonism is the inhibition of DA release in the NA. Thus, the
 
antagonism of drug-induced reward behavior can be utilized to
 
demonstrate the role of the 5-HT3 receptor complex in mesolimbic
 
reward.
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DEVELOPMENTALMPUCAHONS
 
Ontogeny of Neurotransmitter Systems: DA
 
Although the behayioral responses inay yary from those of the
 
adult, it is apparent that Di and D2 receptor actiyation has behayioral
 
effects in preweanling rats. Receptor binding studies suggest that both Di
 
and D2subtypes are present at birth and maintain a 1:1 ratio until 15
 
days postnatally (Gelbard, Teicher, Faedda, & Baldessarini, 1989; Giorgi
 
et al., 1987; Sales, Martres, Bouthenet, & Schwartz, 1989). After this
 
period, Di receptors begin to outnumber D2receptors,with an adult-like
 
ratio occurring by about 60 days of age (Gelbard et al., 1989; Murrin &
 
Zeng, 1986; Zeng, Hyttel, & Murrin, 1988). While the exact deyelopmental
 
implications of this disparity remains uncertain, some behayioral
 
differences haye been determined using psychopharmacological
 
eyidence.
 
Behayioral studies indicate that selectiye DA receptor agonists
 
produce age-dependent behayioral differences in rats. For example, adult
 
rats injected with the Di agonist SKF-38393 or the D2 agonist quinpirole
 
respond with increased grooming or yertical behayior, respectiyely
 
(Moody & Spear, 1992). In contrast, rat pups giyen injections of SKF­
38393 or quinpirole exhibit increased forward locomotion and/or sniffing
 
behayior, while the typical adult behayiors are absent (Moody & Spear,
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1992). Similarly, when rat pups under 17 days old are pretreated with
 
the irreversible DA antagonist N-ethoxyGarbohyl-2-ethoxy-l,2­
dihydroquinoline (EEDQ), the response to DA agonists differs from that of
 
the adult rat. Unlike adults, rat pups fail to exhibit the attenuation of
 
stereotyped behaviors induced by the nonselective agonist R­
propylnorapomorphine (NPA) (McDougall & Bolanos, 1995; McDougall,
 
Crawford, & Nonneman, 1992; Mestlin & McDougall, 1993). In addition,
 
preweanling rats, when compared to adultsv show a greater behavioral
 
response tO psychomotor stimulants like cocaine (Spear & Brick, 1979).
 
In spite of these ontOgenetic differences, evidence suggests the
 
presence of functional Di and D2 receptors in preweanling rats (Moody &
 
Spear, 1992). Nonetheless, it is important to understand the ontogenetic
 
behavioral differences that can be elicited by different combinations of
 
Di, D2 or D1/D2receptor agonist stimulation.
 
Ontogeny of Neurotransmitter Systems: Opiates
 
Evidence indicates that rats as young as 5 days old have
 
functional opioid receptors and possess the ability to respond
 
behaviorally to opiate drugs (Kehoe & Blass, 1986). Binding studies
 
demonstrate that opiate receptors are present and functional 15 days
 
following birth (Bayon, Shoemaker, Bloom, Mauss, & Guillemin, 1979;
 
Khachaturian, Alessi, Munfakh, & Watson, 1983).
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Pharmacological responding can also be an indicator of neonatal
 
opiate receptor maturity. Potential maturity can be assessed by
 
measuring the, ability of rat pups to exhibit morphine-induced CPP (Barr
 
& Rossi, 1992). When a morphine dose, corresponding to the lowest
 
effective adult dose, is injected directly into the VTA of 4-day-old rats,
 
CPP is established. As in adult rats, only localized injections into the
 
VTA, and not the NA or other brain areas, produces CPP in rat pups (Barr
 
& Rossi, 1992). This implies that the neonatal reward system is
 
functional shortly after birth and that opiate reward depends upon VTA
 
activation (Laviola et al., 1992; Moran et al., 1981; Phillips & LePiane,
 
1980).
 
Although adult and preweanling rats exhibit morphine-induced
 
reward, evidence suggests that drug-induced motor behaviors vary
 
considerably (Caza & Spear, 1980). Specifically, a high (5.0 mg/kg) dose
 
of morphine causes a decrease in locomotion and a low (1.0 mg/kg) dose
 
increases locomotor activity in preweanling rats, In contrast, rats older
 
than 17 days exhibit a reversal of this behavioral pattern (Caza & Spear,
 
1980; Spear & Brake, 1983). Importantly, morphine produces CPP in rats
 
as young as 4 days of age (Barr & Rossi, 1992).
 
Importantly, CPP, as evidenced by time spent in the morphine
 
conditioned environment, can be induced through localized VTA or
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systemic injections shortly after birth (Barr & Rossi, 1992). Evidence
 
indicates that rats have functional opiate receptors early in the
 
preweanling period and are capable of performing morphine-induced
 
CPP in a manner similar to adults (Barr & Rossi, 1992; Bayon, Shoemaker,
 
Bloom, Mauss, & Guillemin, 1979; Khachaturian et al., 1983; Laviola et
 
al., 1992; Pruitt et al., 1995).
 
Ontogeny of Neurotransmitter Svstems: Serotonin
 
There is little research assessing the ability of serotonin antagonists
 
to block DA agonist-induced behavior or neurochemical effects in
 
neonatal rats (Pranzatelli, 1992). However, available evidence supports
 
the concept that serotonin is present early in the prenatal period and
 
that some receptor subtypes are functiorial at birth (Pranzatelli, 1992;
 
Pranzatelli, Durkin, & Barkai, 1994). Research suggests that one of the
 
first neurochemical systems to differentiate during ontogeny is serotonin.
 
In the rat, serotonin neurons develop by day 13 of gestation and the
 
serotonin neurotransmitter system becomes functional near the end of
 
term (Eaton, Staley, Mordecai, GlobUs, «& Whittemore, 1995; Whitaker-

Azmitia, 1991). Research also suggests that serotonin is synthesized by
 
raphe fetal cells and performs specific functions early in gestation.
 
Serotonin may actually be produced before synaptic processes are
 
needed, as evidenced by the fact that the fetus has serotonergic neurons
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containing enzymatic material well, before there is synaptic contact
 
made at the terminal level. This suggests that serotonin may actually be
 
synthesized and released within cells of the CNS to function in
 
developmental processes (Eaton et al., 1995; WhitakerrAzmitiaj, 1991). For
 
example, serotonin may guide the development of its own neurons
 
(Eaton et al., 1995) and instigate and control neurite growth (Whitaker-

Azmitia, 1991).
 
Receptor binding studies demonstrate the presence of serotonin
 
receptors in rat pups and pharmacological research suggests functional
 
responsiveness shortly after birth (Daval et al., 1987; H^d & Engel, 1988,
 
Johansson-Wallsten et al., 1993; Pranzatelli et al., 1992, 1994). Utilizing
 
tracer and radiographic techniques, it was found that the 5-HTiaj 5-HT2
 
and 5-HTic serotonin subtypes are present at birth (Daval et al., 1987).
 
Serotonin receptor systems are capable of mediating behavior in
 
neonatal rats. For example, rat pups have an increased sensitivity to the
 
5-HTia receptor agonist 8-OH-DPAT, as indicated by rapid involuntary
 
muscle jerks and an increase in myoclonus. This is what one would
 
expect from a compensatory serotonin (5-HTia) supersensitivity or
 
increased receptor density from repeated exposure (Ashby, Zhang,
 
Edwards, & Wang, 1994; Hard & Engel, 1988; Pranzatelli et al., 1992,
 
1994). However, studies directly measuring preweanling rat sensitivity
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and responsiveness to 5-HT3 agonists or antagonists are nonexistent
 
(Boess & Martin, 1994; Johansson-Wallsten, Berg, & Meyerson, 1993).
 
Nonetheless, evidence suggests that 5-HT3receptors are present shortly
 
after birth, and that the ability of neonates to respond behaviorally to
 
other serotonin agonists is also present a few days following birth
 
(Johansson-Wallsten et al., 1993). For example, serotonin agonists DOI, 8­
OH-DPAT and fenfluramine are capable of inducing
 
psychopharmacological responsiveness from birth to periadolescence,
 
and no discontinuities in behavior have been observed (Hard & Engel,
 
1988; Johansson-Wallsten et al., 1993; Spear & Brake, 1983).
 
In summary, research suggests that preweanling rats possess
 
functional DA, opiate and serotonin receptors, providing them with the
 
ability to develop morphine- and cocaine-induced CPP. It is uncertain,
 
however, whether serotonin receptor antagonism is capable of disrupting
 
morphine- and cocaine-induced CPP in preweanling rats. Such a
 
disruption occurs in adult rats, but the effects of serotonin antagonism
 
on reward have not yet been assessed during the preweanling period.
 
GENERALPURPOSEANDHYPOTHESIS
 
Many drugs of abuse share the common ability to increase
 
extracellular DA levels in the mesolimbic system. It has been suggested
 
that this may actually be the source of their rewarding properties
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(DiChiara & Imperato, 1988). More specifically, the neuronal
 
consequences of cocaine and morphine involve their ability to increase
 
extracellular DA levels within the mesolimbic DA terminal regions,
 
presumably due to the excitation of A10 DA neurons in the VTA (Gysling
 
& Wang, 1983; Leone & DiChiara, 1987). The behavioral consequences of
 
cocaine and morphine involve their ability to induce a state of reward
 
which can be assessed via the CPP paradigm (Bozarth, 1987; Carboni,
 
Acquas, Leone, & DiChiara, 1989; Higgens et al., 1992). In adult rats,
 
acquisition of cocaine- and morphine-induced CPP can be blocked by
 
prior treatment with the S-HTs antagonist MDL-72222. To date, it is
 
unknown whether MpL-72222 will block the expression of cocaine and
 
morphine CPP. MDL-72222 appears to exert its inhibitory effects on
 
reward functioning by its ability to ultimately decrease DA release in the
 
NA (Acquas et al., 1990; Bilsky & Reid, 1991; Carboni, Acquas, Frau, &
 
DiChiara, 1989; Carboni, Acquas, Leone, & DiChiara, 1089; Suzuki et al.,
 
1992). Unfortunately, it is not known in which brain afea these critical
 
5-HT3 receptors are located. Moreover, it has not yet been determined
 
whether 5-HT3 antagonists are capable of modulating the acquisition
 
and expression of cocaine- and morphine-induced reward in the
 
preweanling rat.
 
Therefore, the purpose of this study is two-fold: first, to determine
 
whether systemically injected MDL-72222 (a 5-HT3 antagonist) will block
 
the expression of a previously established cocaine- or morphine-induced
 
CPP in preweanling rats. Second, if MDL-72222 does not block the
 
expression of CPP then we will determine whether systemically injected
 
MDL-72222 is capable of attenuating the acquisition of cocaine- or
 
morphine-induced CPP in preweanling rats.
 
The exact hypotheses are as follows. (1) Both morphine and
 
cocaine are hypothesized to produce CPP in preweanling rats. (2)
 
Systemic treatment with a full dose range of MDL-72222 is predicted to
 
block the expression of morphine- and cqcaine-induced CPP. If
 
systemically injected MDL-72222 does not affect the expression of CPP
 
(see hypothesis 2) then I will assess whether MDL-72222 blocks the
 
acquisition of CPP. (4) It is hypothesized that a full dose range of MDL­
72222 will attenuate the acquisition of morphine- and cocaine-induced
 
CPP.
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mMlMENTl
 
Method
 
Siihjects. Subjects were 122 Cn==7-ll) male and female rats of
 
Sprague-Dawley descent {Harlan Industries/ Indianapolis, IN, USA). The
 
rats were bred and raised at California State University, San Bernardino.
 
Litters were culled to a maximum of 10 pups at 3 days of age. The
 
colony room was maintained at 20-230C and kept under a 12:12 h
 
lightrdark cycle. Rats were tested when 17-19 days old.
 
Apparatus. The testing apparatus was a rectangular plywood
 
chamber that has three compartments separated by removable
 
partitions. The two end compartments measure 15 X 15 X 21 cm high,
 
while the middle compartment measures 9 X 15 X 21 cm high. All
 
compartments are painted gray and are covered by a clear Plexiglas top.
 
One end compartment has rubberized non-slip flooring, whereas the
 
other end compartment has plywood flooring scored (1 cm deep) in a
 
checkerboard fashion. The middle compartment has smooth plywood
 
flooring. Besides the tactile differences, both end compartments are
 
equipped with an odor delivery system. More specifically, beneath each
 
end compartment, and connected via 15 small holes in the floor, are
 
rectangular plastic containers (14 X 7 X 4 cm high) partially filled with
 
pinewood chip bedding. Lemon and almond extracts are applied to the
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 pinewood bedding of each container to provide distinctive odor cues for
 
the end compartments (10 cc of the extract is used for conditioning and
 
1 cc is used for preference testing). During conditioning, solid partitions
 
are used to keep rats in the appropriate compartments, whereas during
 
testing the partitions are raised 5.5 cm so that each rat can move freely
 
between the compartments.
 
Procedure and Drugs.Rat pups were given two 30 min
 
conditioning trials on each of the two consecutive days. On the first
 
conditioning day, the rats were given one saline injection and placed in
 
a novel scented compartment for 30 min. This was repeated 4 hours
 
later. On the second day, the rat pups were injected i.p. with saline,
 
cocaine (20 mg/kg), or morphine (0.5 mg/kg), placed in a chamber for
 
30 min, and presented with a novel odor. The identical procedure was
 
repeated four hours later. Importantly, drug treatment and chamber
 
scent (lemon or almond) were counter-balanced so that scent alone
 
would not confound results.
 
Following the two days of CPP conditioning, rat pups were injected
 
with saline or the selective serotonin 5-HT3 receptor antagonist MDL­
72222. Thirty minutes later rats were given free access to both scented
 
chambers for 15 min. It was predicted that MDL-72222 would block the
 
expression of the cocaine- and morphine-induced place preference (see
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Figure 14 for a summary of this experiment).
 
Data Analysis. Both conditioning sessions and testing sessions were
 
video taped for behavioral assessment by a rater blind to treatment
 
conditions. Total time spent in each compartment was measured in
 
each treatment and control condition. Total time spent in the drug-

paired compartment and locomotor activity (line-crosses) was analyzed
 
using t-tests and analyses of variance (ANOVAs). Significant main effects
 
and interactions were analyzed using Tukey tests.
 
Research Setting. Behavioral assessment was doiie in the vivarium.
 
Results
 
T.ocomotor Activitv. The mean locomotor activity counts of
 
morphine-, cocaine-, and saline-treated rats during conditioning are
 
shown in Figure 15. Overall, cocaine-treated rats had significantly more
 
line-crosses than saline- or morphine-treated rats, F (2,116)= 80.54, P. <
 
.05.
 
rnnditionerl Plaee Preference. MDL-72222 (0.17, 0.5, 1.5, 4.5 mg/kg,
 
IP) failed to significantly block the expression of either morphine- or
 
cocaine-induced CPP in 17-day-old rats (see Figures 16 and 17). More
 
specifically, test day treatment with MDL-72222 did not affect the
 
compartment preference of morphine- or cocaine-treated rats, F(4,40)=
 
1.40, P>.05; F(4,37)= .405, P>.05; respectively.
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EXPRESSION EXPERIMENT
 
Systemic Injections
 
{MDL72222 Given Post-conditioning)
 
Drugs MDL72222 MDL72222 MDL72222 MDL72222
 MDL72222
 
'o.'o mg/kg 0-17 mg/kg 
. t.5 mg/kg o.'5 mg/kg 4.5 mg/kg
 
.i-P- i.p. i.p. i.p. i.p.
 
Coc 20.0
 
mg/kg i.p.
 
Morph 0.5
 
mg/kg i.p.
 
Saline i.p.
 
^ Protocol Design of Expression Experiment.
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LOCOMOTOR ACTIVITY
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Figure 15, Mean number (+SEM) of line-crosses in the drug-paired
 
companment of the CPP apparatus during both conditioning sessions (30
 
nun each). The 17-day-old rat pups were injected with cocaine (20.0
 
mg/kg, IP), morphine (0.5 mg/kg. IP), or saline immediately prior to
 
conditioning (n=7-ll).
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 EXPRESSION OF MORPHINE CPP FOLLOWING DOSES OF MDL-72222
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Figure 16 Mean time that rats spent (seconds) in the morphine-paired
 
chamber (+SEM)' of the CPP apparatus on test day. Thirty min following
 
MDL-72222 (0.0. 0.17, 0.5. ^1.5,, 4.5 mg/kg. IP) treatment each 17-day-oId
 
rat pup was allowed 900 sec access to. the three compartments (n=6-10).
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MDL-72222 (0.0, 0.17. 0.5, 1.5. 4.5 mg/kg, IP) treatment each I7-day-dld 
rat pup was allowed 900 sec access to the /three, compartment (7-10). 
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Surprisingly, test day treatment with MDL did affect compartment
 
preference in saline-conditioned rats (see Figure 18). Post hoc
 
comparisons using Tukey tests (jP < .05), showed that rats receiving the
 
4.5 mg/kg MDL-72222 exhibited a compartment preference.
 
Importantly, morphine and cocaine did produce a place
 
preference (see Figures 19 and 20). Rats treated with 0.5 mg/kg of
 
morphine spent significantly more total time in the drug-paired
 
chamber when compared to saline treated rats, t (15)= -3.35, P. < .05.
 
Similarly, the cocaine group spent significantly more total time in the
 
drug-paired compartment than did rats receiving saline alone, t (14)= ­
2.77, P < .05.
 
Snmmarv
 
MDL-72222, at dosage levels of 0.17 to 4.5 mg/kg, did not
 
significantly affect the expression of morphine- or cocaine-induced CPP.
 
Whereas, morphine or cocaine (given without MDL-72222) was able to
 
induce CPP. Surprisingly, MDL-72222 (at the highest dose) did produce a
 
compartment preference.
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 EXPRESSION.OF MORPHINE CPP
 
.600
 
c/:
 
=, . 500
 
U
 
r ■ 400 
300
 
sZ 00
 
Saline Morphine
 
spent (seconds) in the preferred chamber (+SEM) by
 
saline- or morphine-treated rat pups on test day. The 17-day-old fats
 
were placed into the CPP apparatus 30 min following saline injections and
 
allowed 900 sec access to all three compartments (n=7-M).
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 EXPRESSION Or COCAiNS GPP
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Figure 20. Mean time spent (seconds) in the preferred chamber (+SEM) by
 
saline- or cocaine-treated rat pups on test day. The 17-day-oId rats were
 
placed into the GPP apparatus 30 min following saline injections and
 
allowed 900 sec access to all three compartments (n=7-9).
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EXPERIMENT2
 
Method
 
Subjects. Total subjects numbered 84 (n=7). Otherwise the subjects
 
and apparatus were the same as described in Experiment 1.
 
Procedure and Dru^s. Rat pups were given two 30 min conditioning
 
trials on each of the two cohsecutiye days. On the first conditioning day,
 
the rats were given two saline injections and placed in a novel scented
 
compartment for 30 min. This was repeated 4 hours later. On the second
 
day, n-day-old rat pups were injected i.p. with saline or the selective
 
serotonin 5-HT3 receptor antagonist MDL-72222 (0.5, 1.5, 4.5 mg/kg).
 
Thirty minutes later rats were given a second injection (i.p.) of saline,
 
cocaine (20 mg/kg) or morphine (0.5 mg/kg), placed in a chamber for 30
 
min, and presehted With a novel odor. The identical procedure was
 
repeated four hours later. Importantly, drug treatment and chamber
 
scent (lemon or almond) were counter-balanced so that scent alone
 
would not confound results (see Figure 21) for a summary of this
 
experiment)
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ACQUISITION Experiment
 
Systemic Injections
 
(MDL72222 Given Pre-conditioning)
 
.■Drugs, '. MDI,,72222 MDL72222 MDL72222 ,MDL72222 
0.0 : mg/kg';, . ;C.5 mg/kg 1.5 mg/kg 4.5 mg/kg 
i.p. i.p. i.p. i.p. 
Coc 20.0
 
mg/kg i.p.
 
Mqrph 0.5
 
mg/kg i.p. 
Saline i.p. 
Figt3r-g» 91 Protocol Design of Acquisition Experiment. 
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Following the two days of CPP conditioning, rat pups were injected with
 
saline and were given free access to both scented chambers for 15 min.
 
Pups conditioned with cocaine-alone or morphine-alone should prefer
 
the drug-paired compartment. It was predicted that MDL-72222 would
 
block the acquisition of this cocaine- and morphine-induced preference.
 
Rcshlts
 
Locomotor Activity. The mean locomotor activity counts of
 
morphine-, cocaine-, and saline-treated rats are shown in Figure 22, 23
 
and 24). Each rat pup had received a dose of MDL-72222 (0.0, 0.5, 1.5,
 
4.5 mg/kg, IP) 30 min prior to the drug injections. Overall, cocaine-

treated rats had sighificantly more line-crosses than saline- or morphine-

treated rats, E (2,72)= 90.19, E < .05 (see Figure 23). MDL-72222 did not
 
affect the locomotor activity of the morphine-, cocaine-, or saline-treated
 
rats.
 
Conditioned Place Preference. MDL-72222 (0.17, 0.5, 1.5, 4.5 mg/kg,
 
IP) failed to significantly block the acquisition of either morphine- or
 
cocaine-induced CPP in 17-day-old rats (see Figures 25 and 26). More
 
specifically, MDL-72222 given prior to injections of morphine (0.5 mg/kg,
 
IP) or cocaine (20.0 mg/kg, IP) during conditioning did not affect
 
compartment preference on the test day, F(3,24)= .02, P>.05; F(3,24)= .35,
 
E>.05; respectively.
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E^1h:^_22. Mean number (+SEM) of
 
compartment of the CPP apparatus during both conditioning sessions (30
 
rnin each). The I7-day-qId rat pups were injected with morphine (0.5
 
mg/kg, IP), or saline 30 rnin following a dose of MDL72222 (0.0, 05, 1 5
 
4.5 mg/kg, IP) and placed into the conditioning chamber(n=:7)
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Figure 23- Mean number (+SEM) of line-crosses in the drug-paired
 
compartment of the CPP apparatus during both conditioning sessions (30
 
min each). The 17-day-old rat pups were injected with cocaine (20.0
 
mg/kg, IP), or saline 30 min following a dose of MDL72222 (0.0, 0.5, 1.5
 
4.5 mg/kg, IP) and placed into the conditioning chamber (n=7)­
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effect of MDL-72222 ON THE ACQUISITIOxN
 
OFMORPHINE GPP
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Ej^ure_22. Mean time that rats spent (seconds) in the ^ morphine-paired
 
chamber (-i-SEM) of the CPP apparatus on test day; On the previous day,
 
each 17-day-old rat pup was given .VIDL7:222 (0.0. 0.5. 1.5, 4.5 ms/ks. IP)
 
30 min prior to an injection of .saline or. morphine (0.5 mg/kg, IP) and
 
allowed 900 sec access to the three compartments (n-=7y .
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EFFECT OF MDL-72222 ON THE ACQUISITION
 
OFCOCAINE CPP
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Figure 26. Mean time that rats spent (seconds) in the cocaine-paired
 
chamber (+SEM) of the GPP apparatus on test day. On the previous day,
 
each 17-day-old rat pup, was given MDL72222 (0.0. 0.5. 1.5, 4.5 mg/kg. IP)
 
30 min prior to an injection of saline or cocaine (20.0 mg/kg. IP), and
 
allowed 900 sec access to the three compartments in=7).
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 Treatment with MDL-72222 did not affect compartment preference in
 
saline-conditioned rats, F(3,24)= .85, £>.05 (see Figure 27).
 
On the test day, rat pups showed only a nonsignificant preference
 
for the morphine- or cocaine-paired chamber, t(12)=l.12, £>.05;
 
t (12)=.55, £>.05 respectively (see Figures 25 and 26).
 
Summarv
 
MDL-72222, at dosage levels of 0.5 to 4.5 mg/kg, did not
 
significantly affect the acquisition of morphine- or cocaine-induced CPP.
 
In contrast to Experiment 1, MDL-72222 did not affect compartment
 
preference or action based on cocaine-induced locomotor activity.
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 EFFECT OF MDL.72222 ON THE ACQUISITION
 
OFA PLACEPREFERENCE
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T*. ' ' ^ ■i^ure 27. Mean time that rats spent (seconds) in the saline-paired
 
chamber (-t-SEM) of the CPP apparatus on test day. On the previous dav,
 
each 17-day-oId rat pup was given MDL72222 (00. 0.5. 1.5. 4.5 mg/kg, IP)
 
SO rnin prior to an injection of saline and allowed 900 sec access to the
 
three compartments (n=7).
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DISCUSSION
 
Although there is much evidence to show that the dopamine
 
system in the adult rat is modulated by 5-HT3 receptors (Higgins et al.,
 
1992; Imperato & Angelucci, 1989; Pel et al., 1989; Suzuki et al., 1993),
 
this is the first study to examine the role, if any, played by 5-HT3
 
receptors on the reward processes of the preweanling rat. The results of
 
the present study suggest that the 5-HT3 receptor system may
 
differentially modulate DA- and opioid-mediated reward across
 
ontogeny. More specifically, 5-HT3 receptor antagonists block the
 
cocaine- and morphine-induced CPP of adult rats, while a 5-HT3
 
antagonist did not block CPP in preweanling rats. There are two probable
 
explanations for these results. First, the 5-HT3 receptors of preweanling
 
rats may not modulate DA reward in the same manner as in the adult
 
rat. This has not been adequately examined, although it is known that 5­
HT3 receptors are present and functional shortly after birth (Boess &
 
Martin, 1994; Daval et al., 1987; Hard & Engel, 1988; Johansson-Wallsten
 
et al., 1993; Pranzatelli et al., 1992; 1994). Second, 5-HT3 antagonists
 
may differentially affect the Di or D2 receptors of preweanling rats.
 
Previous research indicates that the DA receptor subtypes of preweanling
 
rats differ in density and expression from those found in adult rats
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(McDougall et sA., l99i^; 1992; Murrin, Gibbens, & Ferrer, 1985; Murrin &
 
Zeng, 1989; 1990; Zeng et al., 1988).
 
Importantly, the preseiit results demonstrate that both morphine-

and cocaine-treated 17-day-old rats showed a robust place preference
 
using the abbreviated CPP procedure. Surprisingiyv this study also clearly
 
demonstrates the inability of MDL-72222 (047, 0.5, 1-5, 4.5 mg/kg, IP) to
 
significantly block either the expression or acquisition of cocaine- and
 
morphine-induced GPP in 17-day-old rats. This differs from previous
 
studies using adult rats which have shown that 5-HT3 antagonists block
 
the initial acquisition of a rewarded behavior (Bilsky & Reid, 1991;
 
Carboni et al., 1989; Higgins etal., 1992). More specifically, niany 5-HT3
 
antagonists, including Ml)L-72222^ have been repeatedly used to
 
attenuate the acquisition of reward, including morphine- and cocaine-

induced CPP (Blandina et al., 1983; 19?9; Gostall et al., 1987; Dyr &
 
Kostowski, 1995; Gifford & Wang, 1994; Grant, 1995). The inability of
 
MDL-72222 to affect CPP in the present study was particularly
 
unexpected because research has suggested that serotdnin levels and 5­
HT receptor subtypes are present and/or functional shortly after birth
 
(Boess & Martin, 1994; Daval et al., 1987; Hard & Engel, 1988; Johansson-

Wallsten et al., 1993; Pranzatelli et al., 1992; 1994). Significantly,
 
research into dopamine receptor functioning across ontogeny has
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demonstrated that differences exist between adult and pre-adult
 
responses within the dopamine system (McDougall et al., 1991; 1992;
 
Murrin et al., 1985; Murrin & Zeng, 1989; 1990; Zeng et al., 1988).
 
Additionally, it was unexpectedly discovered that saline-treated
 
rats given 4.5 mg/kg MDL-72222 on the test day had a significant
 
preference for the compartment used on the previous conditioning day
 
(see Figure 18). This was probably a spurious result since MDL-72222 did
 
not induce CPP when given during conditioning (see Figure 27).
 
The release of dopamine is believed to be essential for associative
 
learning to take place during rewarding experiences (Wickens, Begg, &
 
Arbuthnott, 1996). However, there has been some disagreement
 
pertaining to the differential involvement of Di and D2 receptors in the
 
reward processes of both adult and young rats. Some research using
 
adult rats has suggested that both the Di and D2 receptors are essential
 
for the acquisition of reward (Miller et al., 1990; Nakajima & Baker, 1989;
 
Nakajima & McKenzie, 1986; Wise & Rompre, 1989). In contrast,
 
Shippenberg et al. (1993) have demonstrated that the rewarding effects
 
of opioids, such as morphine, are primarily dependent upon activation
 
of Di post-synaptic receptors located within the NA. Similarly, using
 
adult rats, Hiroi and White (1991a) have demonstrated a differential
 
involvement of dopamine Di and D2 receptor subtypes during the
 
87;
 
expression and acquisition of dopaniine-induced agonist reward. Hiroi
 
and White (1991a) found that D2 receptqr antagonism failed to block the
 
expression of amphetamine-induced CPP. However, expression of a
 
previously established CPP wa? blocked by a post-conditioning treatment
 
of a Di antagonist. They also found that the expression of reward by Di
 
receptors takes place within the NA, which has connections to the
 
amygdala.
 
the different roles played by Di or D2 dopamine receptors in the
 
preweanling rat may explain why 5-HT3 antagonists did not affect
 
reward processes. Quantitative autoradiographic assessment of
 
dopamine Di and D2 receptors has shown that these DA receptor
 
subtypes differ in their quantity and im|)act on the reward system
 
during various developmental stages (McDougall et al., 1991; 1992;
 
Murrin, Gibbens, & Ferrer, 1985; Murrin & Zeng, 1986; 1989; 1990; Zeng et
 
al., 1988) (see Figures 28 and 29). Importantly, preweanlings rats exhibit
 
regional brain differences in receptor density when compared to other
 
developmental time periods. For example, preweanling rats possess a
 
greater number of D2 receptors in the NA, as compared to other forebrain
 
regions (Broaddus & Bennett, 1990; DeVries, Mulder & Schoffelmeer, 1992;
 
Gelbard et al, 1989; McDougall et al., 1991; Murrin & Zeng, 1989; 1990;
 
Zeng, Hyttel & Murrin, 1988). Additionally, McDougall et al. (1991)
 
found that 17-day-old rats not only have a higher density of D2 receptors
 
in the NA, but that they respond differently to D2 antagonism when
 
compared to other age levels. Pruitt et al. (1995) also found a differential
 
rate of receptor functioning and reward responsiveness across ontogeny
 
in a cocaine GPP study assessing the antagonism Of reward by Di and D2
 
receptor blockade. Importantly, they showed that D2antagonists did not
 
block cocaine-induced GPP in 17-day-old rats. It was concluded that Di
 
receptors are responsible for mediating reward in this age group.
 
Preweanling rats show a Di and D2 dopamine receptor ratio of 1:2
 
in the NA. In contrast, D2 receptor levels maintain a steady increase
 
during development, whereas Dj receptors show a sudden increase,
 
peaking just before and following weaning (Gelbard et al., 1989; Murrin
 
& Zeng, 1990). Using Diand D2 receptor antagonists to block GPP at
 
various ages, Pruitt et al. (1995) concluded that Di receptors are
 
critically involved in the reward processes of preweanling rats, especially
 
during this peak increase. Specifically, when Di receptor density is low,
 
as it is in adult and 10-day-old rats, D2 receptor blockade appears to be
 
more effective in antagonizing DA reward. Nonetheless, it has been
 
concluded that Di and D2receptors may be coupled in reward processes
 
(Pruitt et al., 1995). Thus, each receptor subtype cooperates in an
 
89
 
interactive manner to provide tonic motor (D2) S-nd reward sensations
 
(Di) that are necessary for the full expression of the reward system (see
 
also Wickens et al., 1996). This may explain the findings in the current
 
study, which showed that 5-HT3 receptor antagonism failed to affect DA
 
reward in preweanling rats. The sudden increased peak affect of the Di
 
receptor just prior to and following weaning may have prevented the
 
blockade of reward by the S-HTs antagonist (see Figures 28 and 29).
 
Additionally, the role played by memory in conditioned learning
 
is currently being reduced to the level of receptors, as researchers
 
attempt to determine the importance of receptor subtypes for the
 
establishment and retrieval of memory (Pesimone, 1995). Dppainine
 
receptors have been implicated in short-ternt memory and NMDA and
 
AMPA receptors appear to mediate stimulus^affect associations, whereby
 
an animal recognizes aiid evaluates the biological significance of the
 
stimulus (Ono et al, 1995). The retention of the memory of a rewarding
 
experience is believed to be processed within the amygdala (Hiroi &
 
White 1991a; Ono et al, 1995). This brain structure has a high density of
 
Di receptors (Hiroi & White, 1991a; 1991b), and the globus pallidus
 
which connects the NA to the amygdala, is also high in Di receptors
 
(Murrin & Zehg, 1990).
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Regional Developmental Differences in D1 Density
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Figure 29. Mean regional density ofD1 receptors
 
during development ofthe 15-day-old to 21-day-old
 
(Adapted from Murrin&Zeng,1990).
 
92
 
The differential development of dopaniine receptor subtypes have
 
also been found to occur in humans and primates (Hyttel & Amt, 1986;
 
Williams & Goldman-Rakic, 1995). Specifically, dopamine Di receptors
 
have been correlated with certain types of memory and children
 
demonstrate peak densities of these receptors during developmental
 
stages when learning has been shown to be especially accelerated
 
(Desimone, 1995; Williams & Goldman-Rakic, 1995).
 
Along with a developmental increase in memory capacity in
 
children ages 4 to 10 years old, there is a concomitant and temporary
 
excess of Di,as compared to D2,dopamine receptors at this mentally .
 
accelerated age-range in humans (Hyttel & Amt, 1986).
 
As mentioned before, the Di dopamine receptor sites of rats
 
increase dramatically in number on those days just prior to, and
 
following, the weaning period; whereas, D2 receptor density (believed to
 
be important for activity) is greater within the striatum during this time
 
(Broaddus & Benneitt, 1990; DeVries et al., 1992; Gelbard et al., 1989;
 
Murrin & Zeng, 1986; 1990) (see Figure 28). Although speculative, this
 
may relate to an increased need for the experience of reward, the
 
retention of its memory, and its retrieval, possibly through the
 
activation of increased Di receptors, located within the amygdala and
 
surrounding regions (Hiroi & White, 1991b) (see Figure 30).
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The amygdala is believed to be involved in emotionally charged
 
mnemonic proce|sses, playing a large role in conditioned associative
 
learning (Hiroi k White, 1991b; Ono et al., 1995). A rat pup that is
 
nearing the weaning stage needs to more readily retrieve the previously
 
learned connections between rewarding experiences and associated
 
stimuli; the memory of how that reward was obtained. Its' survival
 
depends upon an increased ability tq leam, and to retrieve these
 
memories in the absence of the nurturing mother.
 
The increase in Di receptors at this critical developmental period
 
provides a plausible explanation for the inability of 5-HT3 antagonists to
 
suppress the expression and acquisition of reward in preweanling rats.
 
Receptors capable of suppressing reward at this precarious
 
developmental period must necessarily be tempered.
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CONCLUSION
 
The results of the present study indicate that 5-HT3 receptor
 
functioning differs between preweanling and adult rats. While 5-HT3
 
receptors modulate reward processes of adult rats, they appear to have
 
little effect on the reward functioning of preweanling rats. This may be
 
due to the increased importance of Di receptor functioning at this
 
critical stage of life.
 
The differential involvement of Di and D2 receptors in the
 
expression and acquisition of reward processes in adults, implies that D2
 
receptors have an increased importance in the acquisition of reward,
 
while Di receptors function in the expression of reward (Hiroi & White,
 
1991a; 1991b). The receptors involved in memory processes that occur in
 
relation to the acquisition and expression of conditioned learning is an
 
important area for further research.
 
Until the present study, there have been no studies examining the
 
role of 5-HT3 receptors for the expression or acquisition of reward in
 
preweanling rats. Our findings demonstrate the inability of the specific
 
5-HT3 antagonist MDL-72222 to block the expression and acquisition of
 
morphine- and cocaine-induced reward and I believe that this may be
 
related to the ontogenetic peak of Di receptors which occurs in the
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 preweanling rat (Broaddus & Bennett, 1990; DeVries, Mulder,
 
Schoffelmeer, 1992; Hiroi & White, 1991a; 1991b; Murrin & Zeng,
 
1986;1990; Pniitt et al., 1992).
 
However, it is important to replicate these results by using
 
different experimental designs. Our finding that 5-HT3 antagonism fails
 
to attenuate preweanling DA reward, obviously differs from the adult rat
 
suggesting many other possibilities. The preweanling rat may possess 5­
HT3 receptors that are too immature to respond to the antagonist at the
 
dosage levels tested. Similarly, 5-HT3 antagonism using the abbreviated
 
CPP paradigm, should be repeated in adult rats in order to rule out any
 
spurious differences found in this current study. Possibly, a different
 
paradigm such as the standard CPP procedure or the operant
 
conditioning paradigm could produce differing results. Similarly, the
 
injection of different levels of 5-HT3 antagonist drug may produce a
 
different response in the preweanling rat.
 
Further research is needed to identify the mechanisms involved in
 
serotonin modulation of reward in this age group. However, it remains
 
that the inability of MDL-72222 to block expression of CPP may not be
 
generalizable to adult rats. This is particularly likely, since various 5-HT3
 
antagonists, including MDL-72222, block the acquisition of reward in
 
adult rats (Blandina et al., 1983; 1989; Costall et al., 1987; Dyr &
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Kostowski, 1995; Gilford & Wang, 1994; Grant, 1995; Higgins et al., 1992;
 
Imperato & Angelucci, 1989).
 
In eontrast to adult rats, the present study indicates that 5-HT3
 
antagomsts may be incapable of blocking the acquisition or expression of
 
reward in preweanling rats. I believe that the peak occurrence of Pi
 
receptors at this period of development is related to the inability of the
 
5-HT3receptor antagonist to block morphine- and cocaine-induced
 
reward. The temporary surge of Di receptors in preweanling rats, as
 
compared to D2receptors, may have developed as a survival trait that
 
acts to enhance the retrieval of conditioned associations for the memory
 
of the sensation and the source of the reward. This is the time in rat
 
development when the ability to form these associations is particularly
 
important for the survival of the animal, as maternal nourishment is
 
withheld. Survival of the individual depends upon learning the
 
associations necessary for successful foraging behavior. Reward is an
 
integral aspect of this learning.
 
Further research is needed to confirm the specific effects that 5-HT3
 
receptor antagonists have on Pi receptors, and the specific role, if any,
 
that 5-HT3 receptors have in the reward processes of preweanling rats.
 
The current study confirms that 5-HT3 receptors differentially affect the
 
acquisition and expression of PA reward across ontogeny.
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